PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Extended support helps patients stay smoke-free after hospital discharge

Automated phone calls, stop-smoking drugs increased six-month success rate more than 70 percent

2014-08-19
(Press-News.org) Smokers admitted to U.S. hospitals cannot smoke during their stay and could use this time as an opportunity to quit, but few are able to stay smoke-free after returning home. Now a study published in the August 20 issue of JAMA describes a program that increased the proportion of hospitalized smokers who successfully quit smoking after discharge by more than 70 percent. The system used interactive voice response technology – automated telephone calls – to provide support and stop-smoking medication for three months after smokers left the hospital.

"Most smokers want to quit, and being hospitalized gives them an opportunity to do so because they can't smoke in the hospital. The health problems that led to the hospital admission can give them extra incentive to stop smoking," says Nancy Rigotti, MD, director of the Tobacco Research and Treatment Center at Massachusetts General Hospital (MGH) and the lead author of the JAMA report. "Many smokers get advice to quit in the hospital, but they are rarely connected to resources to help them stay quit when they return home."

The sustained care program developed by the MGH team provides smokers with a series of interactive automated telephone calls beginning two days after discharge and up to three months' supply of the patients' choice of any FDA-approved stop-smoking medication. At each call, the automated system asked patients to indicate whether they were smoking, gave advice on staying smoke-free, encouraged the proper use of medication and offered medication refills. Participants requesting additional help received a call back from one of the program's tobacco treatment counselors.

The study enrolled 397 smokers who had been hospitalized at MGH, received tobacco cessation counseling as inpatients, and indicated that they planned to try quitting after discharge. Half of the group was randomly assigned to receive the sustained care program. The other half received standard care, consisting of a recommendation to use a stop-smoking drug and to call the national tobacco quitline (1-800-QUIT-NOW) for support. At one, three and six months after hospital discharge, participants received assessment calls from study staff, during which they were asked whether they were currently using any tobacco products and whether they had used any stop-smoking medication or tobacco counseling. The six-month follow-up included a biochemical test to confirm participants' self-reports of not smoking.

At each assessment, more patients in the sustained care group reported not smoking – either during the preceding week or throughout the study period – than did patients in the standard care group. Objective testing of tobacco exposure at six months confirmed abstinence in 26 percent of the sustained care group, compared with 15 percent of the standard care group. The authors note that a likely reason for the difference was that the sustained care group used more tobacco cessation counseling and medication – and used medication for a longer period of time – than did the standard treatment group throughout the study.

Offering smokers help to quit smoking during their hospital stay is now a measure of the quality of care for U.S. hospitals developed by the Joint Commission and endorsed by the National Quality Forum. "Our program can help other U.S. hospitals meet this standard and go even further to ensure that patients get the help they need to remain quit once they leave the hospital," says Rigotti, a professor of Medicine at Harvard Medical School. "Hospitals can and should play their part in reducing the burden of tobacco-related death and disease by helping smokers stay smoke-free when they return home."

INFORMATION: Co-authors of the JAMA report are Susan Regan, PhD, Douglas Levy, PhD, Sandra Japuntich, PhD, Elyse Park, PhD, MPH, Joseph Viana, Jennifer Kelley, RN, MA, and Michele Reyen, MPH, MGH Tobacco Treatment and Research Center; and Yuchiao Chang, PhD, and Daniel Singer, MD, MGH Department of Medicine. The study was supported by National Institutes of Health grants RC1 HL099668 and K24 HL004440.

Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH conducts the largest hospital-based research program in the United States, with an annual research budget of more than $785 million and major research centers in HIV/AIDS, cardiovascular research, cancer, computational and integrative biology, cutaneous biology, human genetics, medical imaging, neurodegenerative disorders, regenerative medicine, reproductive biology, systems biology, transplantation biology and photomedicine.


ELSE PRESS RELEASES FROM THIS DATE:

Intervention helps smokers quit following hospital stay

2014-08-19
Among hospitalized adult smokers who wanted to quit, a postdischarge intervention that included automated telephone calls and free medication resulted in higher sustained smoking cessation rates at six months than standard postdischarge advice to use smoking cessation medication and counseling, according to a study in the August 20 issue of JAMA. Cigarette smoking is the leading preventable cause of death in the United States. For the nearly 4 million smokers hospitalized each year, a hospital stay offers a good opportunity to quit smoking because all hospitals are now ...

Over-reliance of pulse oximetry for children with respiratory infection

2014-08-19
Among infants presenting to a pediatric emergency department with mild to moderate bronchiolitis, those with an artificially elevated oxygen saturation reading were less likely to be hospitalized or receive hospital care for more than 6 hours than those with unaltered readings, suggesting that these readings should not be the only factor in the decision to admit or discharge, according to a study in the August 20 issue of JAMA. Bronchiolitis, a viral lower respiratory tract infection, is the leading cause of infant hospitalizations in the United States, with annual costs ...

Study examines incidence, survival rate of severe immunodeficiency disorder in newborns

2014-08-19
Newborn screening performed in numerous states indicates that the incidence of the potentially life-threatening disorder, severe combined immunodeficiency, is higher than previously believed, at 1 in 58,000 births, although there is a high rate of survival, according to a study in the August 20 issue of JAMA. The purpose of newborn screening is early detection of inborn conditions for which prompt treatments can reduce the risk of death or irreversible damage. The first heritable immune disorders to which newborn screening has been applied are those that together comprise ...

Prevalence of HSV type 2 decreases among pregnant women in the Pacific Northwest

2014-08-19
In a study that included approximately 15,000 pregnant women, seroprevalence of herpes simplex virus (HSV) type 2 decreased substantially between 1989 and 2010 while there was no overall decrease for HSV type 1, but a slight increase among black women, according to a study in the August 20 issue of JAMA. Shani Delaney, M.D., and Anna Wald, M.D., M.P.H., of the University of Washington, Seattle, and colleagues examined trends in the seroprevalence of HSV-1 and HSV-2 among pregnant women who delivered newborns at the University of Washington Medical Center between January ...

UCSF-led study finds SCID previously underdiagnosed in infants with fatal infections

2014-08-19
Severe combined immunodeficiency (SCID), a potentially life-threatening, but treatable, disorder affecting infants, is twice as common as previously believed, according to a new study that is the first to examine the national impact of this newborn screening test. The study is the first combined analysis of more than 3 million infants screened for SCID in 10 states and the Navajo Nation. Infants from participating programs born from the start of the first pilot program in January 2008 through July 2013 were included. In May, 2010, SCID was the 29th condition added ...

In-utero methadone, Subutex exposure could alter gene expression, cause severe Neonatal Abstience Syndrome

2014-08-19
(Boston) – Some infants born with neonatal abstinence syndrome (NAS) secondary to in-utero opioid exposure have a more difficult time going through withdrawal than others, but the underlying reasons are not well understood. While genetic and epigenetic (when genes are turned on or off) changes have recently been identified as potential factors, researchers at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) conducted a first of its kind study to identify some of these epigenetic changes that may influence symptom severity. The researchers focused ...

Novel oral anticoagulant prescriptions soar, but at a high cost

2014-08-19
Philadelphia, PA, August 19, 2014 – Warfarin, the longtime standard treatment for atrial fibrillation, is facing competition from new options in the anticoagulant drug marketplace including dabigatran, rivaroxaban, and apixaban. A new study documents the rapid adoption of these novel oral anticoagulants (NOACs) into clinical practice. By mid-2013 NOACs accounted for 62% of all new anticoagulant prescriptions yet this represents 98% of total anticoagulant-related drug costs. Findings are published in The American Journal of Medicine. Atrial fibrillation (AF) is a serious ...

Markey researchers develop web-based app to predict glioma mutations

Markey researchers develop web-based app to predict glioma mutations
2014-08-19
new web-based program developed by University of Kentucky Markey Cancer Center researchers will provide a simple, free way for healthcare providers to determine which brain tumor cases require testing for a genetic mutation. Gliomas – a type of tumor that begins in the brain or spine – are the most common and deadly form of brain cancer in adults, making up about 80 percent of malignant brain cancer cases. In some of these cases, patients have a mutation in a specific gene, known as an IDH1 mutation – and patients who have this tend to survive years longer than those ...

Philippine tarsier gets boost from Kansas research, and genetic proof of a new variety

Philippine tarsier gets boost from Kansas research, and genetic proof of a new variety
2014-08-19
LAWRENCE — It's not a monkey. It's not a lemur. It's not an African Bush Baby or even a Madagascan Mouse. Meet the Philippine tarsier: a tiny, adorable and downright "cool" primate from Southeast Asia. "It's really not like any animals that Americans are familiar with," said Rafe Brown, curator-in-charge at the University of Kansas' Biodiversity Institute. "A tarsier has giant eyes and ears; an extremely cute, furry body; a long tail with a furry tuft at the end; and interesting expanded fingers and toe tips that look a bit like the disks on the digits of tree frogs." Brown ...

New vaccine shows promise as stronger weapon against both tuberculosis and leprosy

New vaccine shows promise as stronger weapon against both tuberculosis and leprosy
2014-08-19
In many parts of the world, leprosy and tuberculosis live side-by-side. Worldwide there are approximately 233,000 new cases of leprosy per year, with nearly all of them occurring where tuberculosis is endemic. The currently available century-old vaccine Bacille Calmette-Guerin, or BCG, provides only partial protection against both tuberculosis and leprosy, so a more potent vaccine is needed to combat both diseases. UCLA-led research may have found a stronger weapon against both diseases. In a study published in the September issue of the peer-reviewed journal Infection ...

LAST 30 PRESS RELEASES:

Individuals with multiple sclerosis face substantially greater risk of hospitalisation and death from COVID-19, despite high rates of vaccination

Study shows obesity in childhood associated with a more than doubling of risk of developing multiple sclerosis in early adulthood

Rice Emerging Scholars Program receives $2.5M NSF grant to boost STEM education

Virtual rehabilitation provides benefits for stroke recovery

Generative AI develops potential new drugs for antibiotic-resistant bacteria

Biofuels could help island nations survive a global catastrophe, study suggests

NJIT research team discovering how fluids behave in nanopores with NSF grant

New study shows association of historical housing discrimination and shortfalls in colon cancer treatment

Social media use may help to empower plastic surgery patients

Q&A: How to train AI when you don't have enough data

Wayne State University researchers uncover potential treatment targets for Zika virus-related eye abnormalities

Discovering Van Gogh in the wild: scientists unveil a new gecko species

Small birds spice up the already diverse diet of spotted hyenas in Namibia

Imaging detects transient “hypoxic pockets” in the mouse brain

Dissolved organic matter could be used to track and improve the health of freshwaters

Indoor air quality standards in public buildings would boost health and economy, say international experts

Positive associations between premenstrual disorders and perinatal depression

New imaging method illuminates oxygen's journey in the brain

Researchers discover key gene for toxic alkaloid in barley

New approach to monitoring freshwater quality can identify sources of pollution, and predict their effects

Bidirectional link between premenstrual disorders and perinatal depression

Cell division quality control ‘stopwatch’ uncovered

Vaccine protects cattle from bovine tuberculosis, may eliminate disease

Andrew Siemion to receive the SETI Institute’s 2024 Drake Award

New study shows how the Crimean-Congo hemorrhagic fever virus enters our cells

Neoadjuvant chemotherapy proves effective for locally advanced penile squamous cell carcinoma

Study flips treatment paradigm in bilateral Wilms tumor, shows resistance to chemotherapy may point toward favorable outcomes

Doctors received approximately $12.1 billion from drug and device makers between 2013-2022

Discovery suggests new strategy against follicular lymphoma

Making the future too bright: how wishful thinking can point us in the wrong direction

[Press-News.org] Extended support helps patients stay smoke-free after hospital discharge
Automated phone calls, stop-smoking drugs increased six-month success rate more than 70 percent